Nektar Therapeutics (NASDAQ:NKTR)

CAPS Rating: 2 out of 5

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines.

Recs

0
Player Avatar b3agle (25.86) Submitted: 5/19/2008 12:48:07 PM : Outperform Start Price: $4.58 NKTR Score: +56.77

Turn around already!

Featured Broker Partners


Advertisement